Ensign Peak Advisors
FOLD

Ensign Peak Advisors’s Amicus Therapeutics FOLD Stock Holding History

Ensign Peak Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-56,206
Closed -$443K – 1703
2025
Q3 		$443K Sell
56,206
-42,600
-43% -$303K ﹤0.01% 1436
2025
Q2 		$566K Hold
98,806
– – ﹤0.01% 1522
2025
Q1 		$806K Hold
98,806
– – ﹤0.01% 1372
2024
Q4 		$931K Hold
98,806
– – ﹤0.01% 1364
2024
Q3 		$1.06M Hold
98,806
– – ﹤0.01% 1294
2024
Q2 		$980K Hold
98,806
– – ﹤0.01% 1290
2024
Q1 		$1.16M Sell
98,806
-4,984
-5% -$63.7K ﹤0.01% 1219
2023
Q4 		$1.47M Hold
103,790
– – ﹤0.01% 1096
2023
Q3 		$1.26M Hold
103,790
– – ﹤0.01% 1026
2023
Q2 		$1.3M Buy
103,790
+4,300
+4% +$51K ﹤0.01% 1064
2023
Q1 		$1.1M Hold
99,490
– – ﹤0.01% 1163
2022
Q4 		$1.21M Buy
99,490
+43,200
+77% +$486K ﹤0.01% 1025
2022
Q3 		$588K Sell
56,290
-177,269
-76% -$1.98M ﹤0.01% 1371
2022
Q2 		$2.51M Buy
233,559
+177,429
+316% +$1.46M 0.01% 724
2022
Q1 		$532K Buy
56,130
+10,130
+22% +$95K ﹤0.01% 1531
2021
Q4 		$531K Buy
+46,000
New +$513K ﹤0.01% 1608
2021
Q1 		– Sell
-117,502
Closed -$2.71M – 1844
2020
Q4 		$2.71M Sell
117,502
-12,605
-10% -$258K 0.01% 882
2020
Q3 		$1.84M Buy
130,107
+124,019
+2,037% +$1.81M ﹤0.01% 1012
2020
Q2 		$92K Hold
6,088
– – ﹤0.01% 1634
2020
Q1 		$56K Sell
6,088
-7,089
-54% -$67.4K ﹤0.01% 1602
2019
Q4 		$129K Buy
+13,177
New +$121K ﹤0.01% 1637

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ensign Peak Advisors's FOLD Position: Q4 2025 in Review

Ensign Peak Advisors sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 56,206 shares — an estimated $443K sold.

Ensign Peak Advisors first reported a position in FOLD in Q4 2019 and held it in 21 quarters. The position peaked at $2.71M in Q4 2020. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Ensign Peak Advisors reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 56,206 Amicus Therapeutics shares in Q4 2025, an estimated $443K.
  • Ensign Peak Advisors first reported a position in Amicus Therapeutics in Q4 2019 and held it in 21 quarters.
  • Ensign Peak Advisors's Amicus Therapeutics position peaked at $2.71M in Q4 2020.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.